| 臺大學術典藏 |
2022-02-22T05:34:39Z |
Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine
|
Chang E.Y.; CHIEN-HUNG CHEN; Ji H.; Wang T.-L.; Hung K.; Lee B.P.; Huang A.Y.C.; Kurman R.J.; Pardoll D.M.; Wu T.-C. |
| 國立臺灣大學 |
2005-11 |
Antigen-Specific CD8(+) T Lymphocytes Generated from a DNA Vaccine Control Tumors Through the Fas-FasL Pathway
|
Cheng, WF; Lee, CN; Chang, MC; Su, YN; Chen, CA; Hsieh, CY |
| 國立臺灣大學 |
2005 |
Antigen-Specific Cd8+ T Lymphocytes Generated from a DNA Vaccine Control Tumors through the Fas-Fasl Pathway
|
鄭文芳; 李建南; 張明誠; 蘇怡寧; 陳祈安; 謝長堯; CHENG, WEN-FANG; LEE, CHIEN-NAN; CHANG, MING-CHENG; SU, YI-NING; CHEN, CHI-AN; HSIEH, CHANG-YAO |
| 臺大學術典藏 |
2020-01-22T07:50:49Z |
Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway
|
Cheng W.-F.;Lee C.-N.;Chang M.-C.;Su Y.-N.;Chi-An Chen;Hsieh C.-Y.; Cheng W.-F.; Lee C.-N.; Chang M.-C.; Su Y.-N.; CHI-AN CHEN; Hsieh C.-Y. |
| 臺大學術典藏 |
2020-02-06T05:22:29Z |
Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway
|
Chen C.-A.; Hsieh C.-Y.; WEN-FANG CHENG; Lee C.-N.; Chang M.-C.; Su Y.-N.; Chen C.-A.; Hsieh C.-Y.; Hsieh C.-Y.;Chen C.-A.;Su Y.-N.;Chang M.-C.;Lee C.-N.;WEN-FANG CHENG; WEN-FANG CHENG; Lee C.-N.; Chang M.-C.; Su Y.-N. |
| 臺大學術典藏 |
2020-02-12T04:06:26Z |
Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway
|
Hsieh C.-Y.;Chen C.-A;Su Y.-N;Chang M.-C;CHIEN-NAN LEE;Cheng W.-F; Cheng W.-F; CHIEN-NAN LEE; Chang M.-C; Su Y.-N; Chen C.-A; Hsieh C.-Y. |
| 臺大學術典藏 |
2005 |
Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway
|
Hsieh C.-Y.; Chen C.-A.; Su Y.-N.; Chang M.-C.; Lee C.-N.; WEN-FANG CHENG; Wen-Fang Cheng;Lee C.-N.;Chang M.-C.;Su Y.-N.;Chen C.-A.;Hsieh C.-Y. |
| 臺大學術典藏 |
2020-11-27T08:14:31Z |
Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway
|
Cheng W.-F.;Lee C.-N.;Chang M.-C.;Su Y.-N.;Chen C.-A.;Chang-Yao Hsieh; Cheng W.-F.; Lee C.-N.; Chang M.-C.; Su Y.-N.; Chen C.-A.; CHANG-YAO HSIEH |
| 臺大學術典藏 |
2021-02-04T06:05:13Z |
Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway
|
Cheng W.-F.;Chien-Nan Lee;Chang M.-C.;Su Y.-N.;Chen C.-A.;Hsieh C.-Y.; Cheng W.-F.; CHIEN-NAN LEE; Chang M.-C.; Su Y.-N.; Chen C.-A.; Hsieh C.-Y. |
| 國立臺灣大學 |
2005-11 |
Antigen-specific CD8+ T lymphocytes generated from a DNA vaccine control tumors through the Fas-FasL pathway.
|
Cheng, WF; Lee, CN; Chang, MC; Su, YN; Chen, CA*; Hsieh, CY |
